Log in to save to my catalogue

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically he...

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically he...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9741502

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Mice bred in 2017 and entered into the C2017 cohort were tested for possible lifespan benefits of (R/S)‐1,3‐butanediol (BD), captopril (Capt), leucine (Leu), the Nrf2‐activating botanical mixture PB125, sulindac, syringaresinol, or the combination of rapamycin and acarbose started at 9 or 16 months of age (RaAc9, RaAc16). In male mice, the combinat...

Alternative Titles

Full title

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9741502

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9741502

Other Identifiers

ISSN

1474-9718,1474-9726

E-ISSN

1474-9726

DOI

10.1111/acel.13724

How to access this item